Loading organizations...
Neoteny 4 operates as an early-stage investment firm, strategically deploying capital into promising ventures across the globe. The firm identifies and supports nascent companies, providing essential funding to help them scale and innovate. Its investment approach focuses on global opportunities within the early development phases of businesses.
The lineage of Neoteny traces back to Joi Ito, who established the original Neoteny in Tokyo in 1999, initially structured as a full-service incubator. This evolved through several iterations, including Neoteny Labs with James Chan in 2009 and Neoteny 3 in 2015. Joi Ito, alongside Adam Mullinax, formally raised Neoteny 4 in 2018, building upon prior experiences in early-stage investment.
Neoteny 4 primarily serves early-stage companies seeking initial investment and strategic partnership to develop their concepts and market presence. The firm’s long-term vision centers on fostering innovation by investing in transformative early-stage businesses worldwide, aiming to contribute to the growth and success of a diverse portfolio of emerging enterprises.
Neoteny 4 has 2 tracked investments across 2 companies. The latest tracked deal is $16.0M Series A in Sonde Health in April 2019.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 11, 2019 | Sonde Health | $16.0M Series A | Edward Kliphuis | Canepa Advanced Healthcare Fund, MP Healthcare Venture Management, PureTech Health |
| Mar 1, 2019 | Dorian | $2.0M Seed | Gregory Milken | Angel Investor, BITKRAFT Ventures, Geek Ventures, UpWest, Charles Huang, Steve Chen, Holly LIU, Jens Hilgers, Jonathan, Kevin LIN, Century Game, David Gardner, MTG |